Skip to content
Grochi · Neutral pet information from South Korea · English edition한국어
Grochi.English edition
Labels & regulation

Who approves veterinary medicinal products in South Korea, and how are they classified?

Translated from the Korean edition · Editorial draft, not professionally reviewed. This page is an English translation of the Korean edition as checked on 2026-11-22. If the two differ, the Korean edition is the reference. 한국어판 (Korean edition)

Who approves veterinary medicinal products in South Korea, and how are they classified?
Short answer

Under a special provision of South Korea's Pharmaceutical Affairs Act (약사법), medicinal products intended only for animal use fall under the Ministry of Agriculture, Food and Rural Affairs and the Ministry of Oceans and Fisheries, with day-to-day work handled by the Animal and Plant Quarantine Agency (APQA) and others. They are divided into medicinal products, quasi-drugs and medical devices, and whether a product is prescription-only is decided separately.

Key takeaways

  • Article 85, paragraph 1 of the Pharmaceutical Affairs Act (약사법) provides that matters under the authority of the Minister of Health and Welfare or the Minister of Food and Drug Safety that concern medicinal products, etc. intended solely for animal use fall under the Minister of Agriculture, Food and Rural Affairs or the Minister of Oceans and Fisheries; so approval of pet medicines takes place in the Ministry of Agriculture, Food and Rural Affairs system, not at the Ministry of Food and Drug Safety (MFDS) that handles human medicines in Korea.
  • The Rules on the Handling of Veterinary Medicinal Products, etc. (동물용 의약품등 취급규칙) define veterinary medicinal products (동물용의약품), veterinary quasi-drugs (동물용의약외품) and veterinary medical devices separately; they require manufacturing-item approval for veterinary medicinal products and some quasi-drugs, and require safety and efficacy review data to be submitted for item approval.
  • The competent agency depends on the intended use: Article 2-2, paragraph 1 of the Handling Rules provides that the Commissioner of the Animal and Plant Quarantine Agency (APQA) is responsible for livestock-related products and others, including companion-animal use (excluding ornamental fish), while the Commissioner of the National Fishery Products Quality Management Service (국립수산물품질관리원) is responsible for fishery-only products, including ornamental fish.
  • Even an approved veterinary medicinal product may be a prescription-only veterinary drug (처방대상 동물용의약품), which cannot be sold without a veterinarian's prescription; this is a separate classification, so whether a product is approved and whether it needs a prescription are different questions.
  • To check whether a product is an approved veterinary medicinal product, you can search for item information in the Veterinary Medicinal Products Integrated Information System (동물용의약품통합정보시스템) of the Animal and Plant Quarantine Agency (APQA), and it is best to read that together with the classification shown on the packaging.

The short answer: approval takes place in a different ministry system from human medicines

In Korea, medicinal products made solely for animal use are approved and managed not by the Ministry of Food and Drug Safety (MFDS), which manages human medicines, but within the system of the Ministry of Agriculture, Food and Rural Affairs (and the Ministry of Oceans and Fisheries for fishery use). The basis is Article 85, paragraph 1 of the Pharmaceutical Affairs Act (약사법). That paragraph provides that, among matters under the authority of the Minister of Health and Welfare or the Minister of Food and Drug Safety under the Act, those concerning medicinal products, etc. intended solely for animal use fall under the authority of the Minister of Agriculture, Food and Rural Affairs or the Minister of Oceans and Fisheries, and it has the references to the minister in the relevant provisions of the Act read accordingly.

The actual work, such as approval applications and review, is carried out not by the minister but through documents submitted to the Commissioner of the Animal and Plant Quarantine Agency (APQA) or the Commissioner of the National Fishery Products Quality Management Service (국립수산물품질관리원) under the Rules on the Handling of Veterinary Medicinal Products, etc. (동물용 의약품등 취급규칙) (hereafter the Handling Rules). These Rules are an ordinance of the Ministry of Agriculture, Food and Rural Affairs.

There is one more distinction. Whether a product has been approved as a veterinary medicinal product and whether it can be bought without a veterinarian's prescription are different questions. The first is the focus of this article, and the second is touched on only briefly below.

This article explains the system. It does not cover which medicine suits your animal or how to give it; those judgments belong to a veterinarian. This article is an editorial draft and has not been through professional review by a veterinarian or pharmacist.

What does Article 85 of the Pharmaceutical Affairs Act specifically provide?

The Pharmaceutical Affairs Act (약사법) is originally a law centered on human medicines, but Article 85 contains "special provisions for veterinary medicinal products, etc." (동물용 의약품 등에 대한 특례), which handle animal medicines within the framework of the same Act. Based on the text of the article as opened and checked on the National Law Information Center (law.go.kr), the main lines of Article 85 are as follows.

  • Paragraph 1: Medicinal products, etc. intended solely for animal use fall under the Minister of Agriculture, Food and Rural Affairs or the Minister of Oceans and Fisheries, who are to consult the Minister of Health and Welfare or the Minister of Food and Drug Safety when setting ministerial ordinances.
  • Paragraphs 2 and 3: The Minister of Agriculture, Food and Rural Affairs or the Minister of Oceans and Fisheries may set use standards, such as target animals, directions for use and dosage, and withdrawal periods, for preparations and the like designated as likely to remain in the body and harm human health, and people who wish to use them must follow those standards. However, the provision says the standards need not be followed when the product is used under the treatment or prescription of a veterinarian or an aquatic animal disease control specialist.
  • Paragraph 4: Under the Veterinarians Act (수의사법), a person who opens an animal hospital may, notwithstanding the general provisions of the Pharmaceutical Affairs Act, sell veterinary medicinal products to animal keepers, and must prepare and keep records of transactions when doing so.
  • Paragraphs 6 to 8: A wholesaler of veterinary medicinal products may not sell certain veterinary medicinal products specified by public notice without a veterinarian's prescription, and exceptions for sales by pharmacy operators and exemptions from the prescription requirement are set out separately.
  • Paragraph 9: People who sell veterinary medicinal products, etc. must follow matters set by ministerial ordinance for establishing distribution systems and sales order and for preventing misuse and abuse.

Two points matter here for pet owners. First, an animal hospital selling medicines directly is not an exception to the Pharmaceutical Affairs Act; it is a structure that this special provision explicitly allows. Second, some medicines require a prescription, and the scope is set by the minister through a public notice, not in the text of the law. The contents of the notice can change, so this article does not reproduce the list.

The provisions of the Pharmaceutical Affairs Act are amended often. The National Law Information Center showed the Act's current effective date as November 12, 2026 (Act No. 21692, partially amended on May 26, 2026); this may have changed by the time you read this, so please check the latest text on the law site.

Who approves? The competent agency depends on the intended use

Article 2-2, paragraph 1 of the Rules on the Handling of Veterinary Medicinal Products, etc. (동물용 의약품등 취급규칙) divides the manufacturing, import and sales work for veterinary medicinal products and veterinary quasi-drugs by jurisdiction. Products for livestock, beekeeping, silkworm rearing and companion-animal use (excluding ornamental fish), and those for combined agricultural and fishery use, fall under the Commissioner of the Animal and Plant Quarantine Agency (APQA), while fishery-only products, including those for ornamental fish, fall under the Commissioner of the National Fishery Products Quality Management Service (국립수산물품질관리원). The words "dogs and cats" do not appear directly in the provision, but it is natural to read dog and cat medicines as falling into the companion-animal category, so they appear to be under the Animal and Plant Quarantine Agency (APQA) (Grochi's reading).

Paragraph 2 of the same article places the manufacturing, import and sales work for veterinary medical devices and veterinary in vitro diagnostic medical devices under the Commissioner of the Animal and Plant Quarantine Agency (APQA). In other words, only fishery-only medicines are split off, and all medical devices fall under the Quarantine Agency.

For medicines for combined agricultural and fishery use, the Commissioner of the Quarantine Agency must hear the opinion of the Commissioner of the National Fishery Products Quality Management Service in advance on the fishery portion when conducting the safety and efficacy review. Meanwhile, the National Law Information Center also showed a scheduled-amendment notice that some provisions of these Rules change from January 1, 2027. Among the provisions marked as scheduled to take effect, in Article 2-2 the wording dividing jurisdiction in paragraphs 1 and 2 was the same as the current text and only the article numbers cited in paragraph 3 differed; the other scheduled provisions were not read. It is safer to check the latest text as that date approaches.

On the website of the Animal and Plant Quarantine Agency (APQA), there were Veterinary Medicinal Products and Veterinary Medicinal Products Evaluation menus under the animal disease control menu, an online illegal sales of veterinary medicinal products menu under the public participation menu, and veterinary medicinal products e-civil petitions in the shortcut list. That this agency handles approval work rests on the provisions of the Handling Rules; the website menus are material for checking the work guidance as a supplement.

What is the approval process? Manufacturing business, item approval, import

The Rules on the Handling of Veterinary Medicinal Products, etc. (동물용 의약품등 취급규칙) manage the companies that make or import medicines and the individual products separately. The flow worth knowing for pet owners is as follows.

  • Company stage: Article 4 sets the procedure by which a person seeking a manufacturing business license for veterinary medicinal products, veterinary medical devices and the like under Article 31, paragraph 1 and other provisions of the Pharmaceutical Affairs Act (약사법), and a person seeking to report a manufacturing business for veterinary quasi-drugs under Article 31, paragraph 4 of the same Act, submit documents to the Commissioner of the Quarantine Agency or the Commissioner of the National Fishery Products Quality Management Service (국립수산물품질관리원). For imports, Article 15 sets the procedure for reporting an import business for veterinary medicinal products and veterinary quasi-drugs.
  • Product stage: Article 5 lists the veterinary medicinal products, etc. that must obtain manufacturing-item approval: veterinary medicinal products, veterinary quasi-drugs falling under Article 2, paragraph 1, item 3 (a) of the Rules (excluding items designated by public notice as subject to reporting), veterinary medical devices of a certain grade or higher, and so on. Imported products obtain import-item approval under Article 16.
  • Reporting stage: Article 5 also separately sets the products subject to manufacturing-item reporting. These include quasi-drugs under Article 2, paragraph 1, item 3 (b) of the Rules (fiber and rubber products and the like for treatment, alleviation, management or prevention purposes) and grade 1 veterinary medical devices that are substantially equivalent to items already approved or reported. Approval and reporting are different procedures.
  • Review stage: Article 7 requires a person seeking item approval for a veterinary medicinal product or quasi-drug to undergo a safety and efficacy review, and lists the submitted data as origin and development history, structure determination and physicochemical properties, stability, toxicity, pharmacological action, clinical trial results, use status in foreign countries, and so on. The detailed requirements for the data are set by the Commissioner of the Quarantine Agency or the Commissioner of the National Fishery Products Quality Management Service.
  • Contract manufacturing: Article 5 requires a consignment and contract manufacturing agreement to be submitted for veterinary medicinal products that are manufactured and sold by commissioning a manufacturer, and Article 4-2 sets the reporting of a contract-manufacturing sales business for veterinary medicinal products.

In summary, veterinary medicinal products in Korea have two overlapping stages: licensing or reporting of the company, and a safety and efficacy review and approval of each individual product. Article 11 of the Rules concerns the approval register and approval certificate, and Article 24 concerns changes to approved particulars. The details of these provisions were not read for this article, so they are not explained here.

The Handling Rules have been amended several times. The current effective-date notation confirmed on the National Law Information Center was October 31, 2025 (Ministry of Agriculture, Food and Rural Affairs Ordinance No. 741, amendment under other laws).

How do veterinary medicinal products, quasi-drugs and medical devices differ?

Even on the same store shelf, legally different kinds of goods are mixed together. Article 2, paragraph 1 of the Handling Rules defines these three separately. Veterinary quasi-drugs are covered in a sibling article, so only their place in the classification is noted briefly here.

A veterinary medicinal product is defined as a medicinal product intended solely for animal use, including medicinal products for beekeeping, silkworm rearing, fishery and companion-animal use (including ornamental fish). A veterinary quasi-drug is a product that has a mild effect on animals or does not act on them directly and is not an instrument or machine, such as companion-animal preparations like mouth fresheners, cleaners and deodorants, disinfectants for disease control, pest control agents, and vitamin preparations as nutritional supplements, as well as fiber and rubber products and the like for treating, alleviating, managing or preventing disease, and it must be one designated by public notice of the Commissioner of the Animal and Plant Quarantine Agency (APQA) or others. A veterinary medical device is a medical device for animal use that has been designated by public notice of the Commissioner of the Quarantine Agency.

The three classifications defined by Article 2, paragraph 1 of the Handling Rules (summary)
ClassificationDefinition in the Handling Rules (summary)Product-stage procedure
Veterinary medicinal products (동물용의약품)Medicinal products intended solely for animal use. Includes companion-animal medicinal productsManufacturing and import item approval and safety and efficacy review (Articles 5, 7 and 16)
Veterinary quasi-drugs (동물용의약외품)Products with a mild effect on animals or no direct action (item a), and fiber and rubber products and the like for treatment or prevention purposes (item b), as designated by public noticeItem (a) is subject to item approval and item (b) to item reporting (Article 5)
Veterinary medical devices (동물용의료기기)Medical devices for animal use designated by public notice of the Commissioner of the Quarantine AgencyApproval or reporting depending on grade (Article 5)

Prescription status: another classification

Approved veterinary medicinal products are divided once more into two. Article 2, paragraph 1, item 10 of the Handling Rules defines a prescription-only veterinary drug (처방대상 동물용의약품) as a veterinary medicinal product that cannot be sold without a prescription from a veterinarian or an aquatic animal disease control specialist. Article 85, paragraph 6 of the Pharmaceutical Affairs Act (약사법) prohibits wholesalers from selling without a prescription medicines specified by public notice, such as those with a risk of misuse and abuse, those requiring a veterinarian's expertise, and those that may cause problems because of their dosage form and pharmacological action. Article 85, paragraph 7 of the Act allows pharmacy operators to sell such medicines without a prescription, with an exception that excludes injectable antibiotic preparations and injectable biological preparations.

So the system can be summed up in one line. Whether a product has been approved is a question of item approval by the competent agency, and whether a prescription is needed is a question of whether the medicine has been designated as prescription-only. Prescription-only designation is made by public notice and the list can change, so whether a specific ingredient is prescription-only right now has to be checked with an animal hospital, an animal pharmacy or the Animal and Plant Quarantine Agency (APQA) information, not this article. The details of this distinction are covered in a separate article.

One more point: an approved medicine is not usable for any animal. Article 5, paragraph 3 of the Handling Rules has the item approval application documents include documents stating the efficacy and effects and the directions for use and dosage, and use outside the range set for each product is something to be discussed only under a veterinarian's clinical judgment. Dosing suited to weight and health condition must follow the product instructions and the veterinarian's guidance.

How does this differ from systems abroad?

Approval agencies and classifications differ from country to country, so it is hard to apply a product or information seen abroad directly to the Korean system. The comparison below is limited to what was read on the official pages that were opened.

In the United States, the Center for Veterinary Medicine (CVM) of the Food and Drug Administration (FDA) approves animal drugs. The FDA page explains that under the Federal Food, Drug, and Cosmetic Act, in most cases an animal drug must be approved by the FDA before it can be sold, and that the FDA reviews safety and effectiveness, manufacturing adequacy, and whether labeling and packaging are appropriate. The same page also introduces a conditional approval system for drugs that do not yet meet the effectiveness standard. The page also explains that, for drugs mixed into feed, a drug is approved for general sale if veterinary oversight is not needed and as a Veterinary Feed Directive (VFD) drug if it is needed; this concerns medicating feed and is a different matter from whether a pill for a pet requires a prescription.

In the European Union, the European Medicines Agency (EMA) has a role in the centralized authorization procedure. The EMA page explains that Regulation (EU) 2019/6 on veterinary medicinal products has applied since January 28, 2022, and that an authorization granted through the centralized procedure is valid across EU Member States and Iceland, Liechtenstein and Norway. The details of national authorization procedures could not be read on that page, so they are not covered.

Few differences with Korea can be stated definitively. The differences in structure that stood out within the scope checked are as follows.

  • Korea hands only the jurisdiction to the Ministry of Agriculture, Food and Rural Affairs side within the same Act as human medicines, through a special provision of the Pharmaceutical Affairs Act (약사법), whereas in the United States there is a center for animal drugs within the FDA.
  • Korea has a separate classification of veterinary quasi-drugs and a dual approval-or-reporting procedure in the Handling Rules, but the corresponding classifications in the United States and the EU were not checked this time.
  • As a rule, even a product approved abroad must obtain import-item approval in Korea, and Article 16 of the Handling Rules sets that procedure. Article 7 includes data on use status in foreign countries among the review data.

Therefore, an animal medicine bought directly from overseas or purchased while traveling, even if it is a legitimate product abroad, is a separate matter from whether it is approved in Korea, and it is safer not to use it before checking.

What pet owners can check

Once you know the approval system, there are things you can check in front of a product. The table below is not a table that gives the answer; it is a checklist of where to look.

The reason to look first at the classification printed on the packaging, as in the first row of the table, is that Article 2, paragraph 1 of the Handling Rules defines veterinary medicinal products, veterinary quasi-drugs and veterinary medical devices separately, and Article 5 divides the product-stage procedures into approval and reporting. Whether a product is approved can be checked not from the advertising text on the packaging but from public information such as the veterinary medicinal products and quasi-drugs information search in the Veterinary Medicinal Products Integrated Information System (medi.apqa.go.kr) of the Animal and Plant Quarantine Agency (APQA). However, you need to check on the site itself which search fields can be used.

On the sales side, Article 85, paragraph 4 of the Pharmaceutical Affairs Act (약사법) sets sales by the person who opens an animal hospital and the preparation and keeping of transaction records, and paragraph 6 sets the restriction on wholesalers selling without a prescription. Whether a medicine needs a prescription is set by public notice and can change, so it should be checked each time with an animal hospital or animal pharmacy, not this article. If you see anything unusual after giving a medicine, please tell a veterinarian first, before looking for product information.

Where to check when buying an animal product
What to checkWhereWhy it matters
Whether the product is labeled as a veterinary medicinal product, quasi-drug or medical deviceProduct packaging and instructionsThe approval or reporting procedure and the way of selling differ by classification
Whether it comes up as an approved itemVeterinary medicinal products and quasi-drugs information search in the Veterinary Medicinal Products Integrated Information SystemYou can check approval from public information, not from advertising text on the packaging
Whether the target animal and efficacy and effects apply to my animalApproved particulars, product instructionsApproval is granted for a defined target animal and range of use
Whether it is a medicine that needs a prescriptionAnimal hospital, animal pharmacy, Animal and Plant Quarantine Agency (APQA) informationPrescription-only designation can change by public notice
Who sells itAnimal hospital, animal pharmacy, etc.Article 85 of the Pharmaceutical Affairs Act sets who may sell and the duty to keep transaction records
Whom to consult if an adverse reaction occursVeterinarianIf an adverse reaction appears, it is safer to tell a veterinarian first. An official reporting procedure was not confirmed in this article

Common misunderstandings and when to consult a professional

There is a misunderstanding that "since it is sold at a human pharmacy, it was approved by the same standard for animals." As seen above, medicines used solely for animals are approved under a separate jurisdiction, and approval of a human medicine says nothing certain about safety for animals. This article does not cover using human or livestock medicines in place of pet medicines. It only notes that risks differ for each animal and can be dangerous.

There is also the misunderstanding that "it says supplement, so it is not a medicinal product." The Handling Rules do have a part that defines vitamin preparations as nutritional supplements and the like as quasi-drugs, but the standard is the approval, reporting or registration category, not the name. This distinction is covered in another article.

The idea that "it was approved, so it is safe for everyone" also calls for caution. Approval means that the submitted data were reviewed and safety and efficacy were recognized for the specified target and directions for use; it does not mean there are no side effects in every animal and situation.

In the following cases, contact an animal hospital first, before looking for product information. If, after taking a medicine, vomiting does not stop, breathing seems difficult, there are convulsions, or the animal is limp and unresponsive, go to an animal hospital immediately. If a human medicine or another animal's medicine has been swallowed by mistake, do not worry about the amount; call an animal hospital right away. When you are unsure about the classification of a prescribed medicine or where to buy it, asking the veterinarian is the most accurate way.

Frequently asked questions

Q Does the Ministry of Food and Drug Safety approve veterinary medicinal products?

No. Under Article 85, paragraph 1 of the Pharmaceutical Affairs Act (약사법), medicinal products, etc. intended solely for animal use fall under the Minister of Agriculture, Food and Rural Affairs or the Minister of Oceans and Fisheries, and under the Handling Rules the actual application is made to the Commissioner of the Animal and Plant Quarantine Agency (APQA) or the Commissioner of the National Fishery Products Quality Management Service (국립수산물품질관리원). The classification of medicinal products used for both humans and animals is not covered in this article.

Q Which agency has jurisdiction over medicines for pets?

Article 2-2, paragraph 1 of the Handling Rules places companion-animal use (excluding ornamental fish) under the Commissioner of the Animal and Plant Quarantine Agency (APQA). Fishery-only products, including those for ornamental fish, fall under the Commissioner of the National Fishery Products Quality Management Service (국립수산물품질관리원).

Q How do veterinary quasi-drugs differ from veterinary medicinal products?

The Handling Rules define veterinary quasi-drugs as products with a mild effect on animals or no direct action, among others, and make them subject to public notices of the Commissioner of the Quarantine Agency and others. A veterinary medicinal product is a medicinal product intended solely for animal use. They also differ in that item (a) quasi-drugs are subject to item approval and item (b) quasi-drugs to item reporting.

Q Can an approved medicine be bought without a prescription?

Approval and prescription are different classifications. Article 2 of the Handling Rules defines a prescription-only veterinary drug as one that cannot be sold without a veterinarian's prescription, and the scope is set by public notice. Whether a specific medicine is prescription-only should be checked with an animal hospital, an animal pharmacy or Animal and Plant Quarantine Agency (APQA) information.

Q Is it all right for an animal hospital to sell medicines directly?

Article 85, paragraph 4 of the Pharmaceutical Affairs Act (약사법) provides that a person who opens an animal hospital may sell veterinary medicinal products to animal keepers, and must prepare and keep records of transactions when doing so. It is a structure the system allows.

Q If a medicine is approved abroad, can it be used in Korea?

Approval abroad and approval in Korea are separate. Article 16 of the Handling Rules sets the import-item approval procedure for imported veterinary medicinal products, etc., so even for a foreign product you need to check whether it is approved under Korean standards.

Q Where can I check whether a product is an approved item?

The Veterinary Medicinal Products Integrated Information System (동물용의약품통합정보시스템) of the Animal and Plant Quarantine Agency (APQA) has a veterinary medicinal products and quasi-drugs information search menu. You need to check on the site itself which search fields can be used.

Limits and scope of this guide

This article is an editorial draft that explains the broad framework of approval and classification within the scope of the provisions of Article 85 of the Pharmaceutical Affairs Act (약사법) and some provisions of the Rules on the Handling of Veterinary Medicinal Products, etc. (동물용 의약품등 취급규칙) that were opened and checked directly, and it has not been through professional review by a veterinarian or pharmacist. The specific list in the public notice designating prescription-only veterinary drugs, the detailed procedures for fishery medicines, the Handling Rules provisions on the approval register, change of approval and post-approval management, the prescription classifications and corresponding quasi-drug classifications in the United States and the EU, and the details of each country's approval procedures were not read this time and are not covered. Laws are often amended, and the Handling Rules also showed provisions scheduled to take effect on January 1, 2027, so please check the latest text on the law site. Whether to use a specific product or how much to give is outside the scope of this article and does not replace a veterinarian's care.

Translated from the Korean edition · Editorial draft, not professionally reviewed. The Korean edition is an explainer newly written from public sources; it is not a full translation of those sources. Veterinary expert review has not been completed. For decisions about your pet's health, talk to a veterinarian who knows your pet.

Sources and check dates

  1. Pharmaceutical Affairs Act, Article 85 (Special Provisions for Veterinary Medicinal Products, etc.) (약사법 제85조(동물용 의약품 등에 대한 특례)) ↗

    Used as the basis for the provisions on transfer of jurisdiction, use standards, sales by animal hospitals, and medicines that cannot be sold without a prescription.

  2. Rules on the Handling of Veterinary Medicinal Products, etc. (동물용 의약품등 취급규칙) ↗

    Used as the basis for the definitions in Article 2, jurisdiction in Article 2-2, approval and reporting targets in Article 5, review in Article 7, imports in Articles 15 and 16, sales in Articles 21 and 22-3, and so on.

  3. Animal and Plant Quarantine Agency website (농림축산검역본부 홈페이지) ↗

    Used to check the veterinary medicinal product menus under animal disease control and the link to e-civil petitions. The former qia.go.kr address has moved to this address.

  4. Veterinary Medicinal Products Integrated Information System (Veterinary Medicinal Products Hideout) (동물용의약품통합정보시스템(동물용의약품 아지트)) ↗

    Used as the basis for the existence of the veterinary medicinal products and quasi-drugs information search menu and the item approval status posting menu.

  5. Development & Approval Process ↗

    Used as the basis for the explanation that animal drugs in the United States require approval before sale and are reviewed for safety, effectiveness, manufacturing and labeling.

  6. Veterinary regulatory: overview ↗

    Used as the basis for the EU veterinary medicines regulation (Regulation (EU) 2019/6) and the scope of validity of the centralized authorization procedure.

Korean edition checked · translated · each source may have a different check date. No paid partnerships.

This guide relies on 3 Korean laws or notices. Current effective dates and upcoming amendments are listed on Korean law check status. This is not legal advice.